As a self-governing industry association, the DoseID Consortium is building the future of item-level visibility of drug products and working to ensure the quality and performance of RFID medication tracking. The consortium brings together leading companies in the pharmaceutical supply chain:

The DoseID Consortium is lead by a Board of Directors, made up of executive representatives from the founding corporate partners, with the following goals:

• Set the vision & mission of DoseID
• Designate working groups & approve standards that each working group designates
• Appoint the independent chair
• Appoint the testing lab & other key service providers central to the mission
• Set budget & fee schedule

Working groups will then:

• Collaborate on standards & certifications
• Evolve standards to meet the needs of the different constituents
• Monitor standard effectiveness
• Recommend and approve standards to be ratified to the board
• Set designated certifications and requirements/guidelines

Governance Documents

• Certificate of Incorporation
• Bylaws
• Membership Agreements
  • for Industry Members
  • for Nonvoting Members (hospitals)
• IPR Policy
• Antitrust Policy

NOTE: Links to additional documents coming in Q3 2021.